Search research articles
Contact Us
Filters
Showing results (11-20 of 93) with videos related to
Page
of 10
Sort By:
Cardiovascular Drugs and Therapy
|
November 21, 2001
In vitro susceptibility and eradication of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells
J Gieffers, W Solbach, M Maass
Parasitology Today (Personal Ed.)
|
June 1, 1990
Evasion strategies of Leishmania parasites
C Bogdan, M Röllinghoff, W Solbach
Clinical and Experimental Immunology
|
June 1, 1978
Effect of niridazole in cellular immunity in vivo and in vitro
W Solbach, H Wagner, M Röllinghoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2000
Cardiovascular infection by Chlamydia pneumoniae is not related to apolipoprotein E genotype
J Gieffers, W Solbach, M Maass
Infection and Immunity
|
December 1, 1986
Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice
W Solbach, K Forberg, M Röllinghoff
Annales De L'Institut Pasteur. Immunology
|
September 1, 1987
Anti-infectious responses in Leishmania major-infected BALB/c mice injected with recombinant granulocyte-macrophage colony-stimulating factor
W Solbach, J Greil, M Röllinghoff
International Immunology
|
October 1, 1996
Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism
A Hoerauf, M Röllinghoff, W Solbach
Klinische Wochenschrift
|
January 17, 1983
[The role of interleukin-2 during the activation of cytotoxic T-lymphocytes]
W Solbach, M Röllinghoff, H Wagner
Cell Death & Disease
|
January 19, 2016
IL-16 and MIF: messengers beyond neutrophil cell death
S Roth, W Solbach, T Laskay
Antimicrobial Agents and Chemotherapy
|
October 3, 1998
In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries
J Gieffers, W Solbach, M Maass
Page
of 10
Search research articles
Search
Showing results (11-20 of 93) with videos related to
Sort By:
Page
of 10
Cardiovascular Drugs and Therapy
|
November 21, 2001
In vitro susceptibility and eradication of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells
J Gieffers, W Solbach, M Maass
Parasitology Today (Personal Ed.)
|
June 1, 1990
Evasion strategies of Leishmania parasites
C Bogdan, M Röllinghoff, W Solbach
Clinical and Experimental Immunology
|
June 1, 1978
Effect of niridazole in cellular immunity in vivo and in vitro
W Solbach, H Wagner, M Röllinghoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2000
Cardiovascular infection by Chlamydia pneumoniae is not related to apolipoprotein E genotype
J Gieffers, W Solbach, M Maass
Infection and Immunity
|
December 1, 1986
Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice
W Solbach, K Forberg, M Röllinghoff
Annales De L'Institut Pasteur. Immunology
|
September 1, 1987
Anti-infectious responses in Leishmania major-infected BALB/c mice injected with recombinant granulocyte-macrophage colony-stimulating factor
W Solbach, J Greil, M Röllinghoff
International Immunology
|
October 1, 1996
Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism
A Hoerauf, M Röllinghoff, W Solbach
Klinische Wochenschrift
|
January 17, 1983
[The role of interleukin-2 during the activation of cytotoxic T-lymphocytes]
W Solbach, M Röllinghoff, H Wagner
Cell Death & Disease
|
January 19, 2016
IL-16 and MIF: messengers beyond neutrophil cell death
S Roth, W Solbach, T Laskay
Antimicrobial Agents and Chemotherapy
|
October 3, 1998
In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries
J Gieffers, W Solbach, M Maass
Page
of 10